This site is intended for UK Healthcare Professionals only
Medicine CentralMedicine Central

Evidence

Browse all clinical evidence, news, and expert commentary

GLP-1 for Alzheimer's? EVOKE trial says no
Neurology

GLP-1 for Alzheimer's? EVOKE trial says no

The EVOKE trials are in, and the answer is no. Novo Nordisk has terminated the programme and discontinued the planned one-year extension of both trials.

5 months ago · 3 min read
Page 1

Medical Disclaimer: The content on Medicine Central is intended solely for registered UK healthcare professionals and is provided for educational and informational purposes only. It does not constitute medical advice, clinical guidance, or a substitute for professional clinical judgment. Always refer to current NICE guidelines, local formularies, and your own clinical assessment when making patient care decisions. Medicine Central accepts no liability for any loss, harm, or damage arising from reliance on the information provided. Content is reviewed periodically but may not reflect the most recent evidence or guideline updates. This site is not intended for use by patients or the general public.

Medicine CentralMedicine Central

Clinical education and evidence for UK primary care. Free for registered healthcare professionals.

Newsletter

The weekly Medicine Central newsletter: curated clinical evidence for UK primary care. Free, and you can unsubscribe at any time.

Join free

© 2026 Medicine Central. All rights reserved.

Privacy PolicyTerms & ConditionsDisclaimerCookie PolicyUnsubscribe